This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hong, P. W.-P.
Right arrow Articles by Lee, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, P. W.-P.
Right arrow Articles by Lee, B.

 Previous Article  |  Next Article 

Journal of Virology, August 2007, p. 8325-8336, Vol. 81, No. 15
0022-538X/07/$08.00+0     doi:10.1128/JVI.01765-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Identification of the Optimal DC-SIGN Binding Site on Human Immunodeficiency Virus Type 1 gp120{triangledown}

Patrick W.-P. Hong,1 Sandra Nguyen,1 Sophia Young,1 Stephen V. Su,1 and Benhur Lee1,2,3*

Department of Microbiology, Immunology and Molecular Genetics,1 Department of Pathology and Laboratory Medicine,2 AIDS Institute, School of Medicine, University of California—Los Angeles, Los Angeles, California 900953

Received 15 August 2006/ Accepted 5 May 2007

Human immunodeficiency virus type 1 (HIV-1) envelope (gp120) binding to DC-SIGN, a C-type lectin that can facilitate HIV infection in cis and in trans, is largely dependent on high-mannose-content moieties. Here, we delineate the N-linked glycosylation (N-glycan) sites in gp120 that contribute to optimal DC-SIGN binding. Soluble DC-SIGN was able to block 2G12 binding to gp120, but not vice versa, suggesting that DC-SIGN binds to a more flexible combination of N-glycans than 2G12. Consistent with this observation, HIV strain JRCSF gp120 prebound to 2G12 was 10-fold more sensitive to mannan competition than gp120 that was not prebound in a DC-SIGN cell surface binding assay. The analysis of multiple mutant forms of the 2G12 epitope revealed one triple glycosylation mutant form, termed 134mut (carrying N293Q, N382Q, and N388Q mutations), that exhibited a significant increase in sensitivity to both mannan competition and endoglycosidase H digestion compared to that of the 124mut form (carrying N293Q, N328Q, and N388Q mutations) and wild-type gp120 in a DC-SIGN binding assay. Importantly, no such differences were observed when binding to Galanthus nivalis was assessed. The 134mut form of gp120 also exhibited decreased binding to DC-SIGN in the context of native envelope spikes on a virion, and virus bearing 134mut exhibited less efficient DC-SIGN-mediated infection in trans. Significantly, 124mut and 134mut differed by only one glycosylation site mutation in each construct, and both 124mut and 134mut viruses exhibited wild-type levels of infectivity when used in a direct infection assay. In summary, while DC-SIGN can bind to a flexible combination of N-glycans on gp120, its optimal binding site overlaps with specific N-glycans within the 2G12 epitope. Conformationally intact envelopes that are DC-SIGN binding deficient can be used to probe the in vivo biological functions of DC-SIGN.


* Corresponding author. Mailing address: Dept. of Microbiology, Immunology, and Molecular Genetics, 3825 MSB, UCLA, 609 Charles E. Young Dr. East, Los Angeles, CA 90095. Phone: (310) 794-2132. Fax: (310) 267-2580. E-mail: bleebhl{at}ucla.edu

{triangledown} Published ahead of print on 23 May 2007.


Journal of Virology, August 2007, p. 8325-8336, Vol. 81, No. 15
0022-538X/07/$08.00+0     doi:10.1128/JVI.01765-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Cui, J., Smith, T., Robbins, P. W., Samuelson, J. (2009). Darwinian selection for sites of Asn-linked glycosylation in phylogenetically disparate eukaryotes and viruses. Proc. Natl. Acad. Sci. USA 106: 13421-13426 [Abstract] [Full Text]  
  • de Witte, L., Bobardt, M., Chatterji, U., Degeest, G., David, G., Geijtenbeek, T. B. H., Gallay, P. (2007). Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc. Natl. Acad. Sci. USA 104: 19464-19469 [Abstract] [Full Text]